M. Morgan

M. Morgan, J. Mikuta, Y. Gincherman, 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Cervical cancer.

Kathleen R. Cho, M. Morgan, N. Dupont, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis

M. Morgan, A. Haggerty, E. Ko, 2021, International Journal of Gynecological Cancer.

Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions.

M. Morgan, J. Grisso, J. Schlesselman, 2000, American journal of epidemiology.

Oral Contraceptives, Other Methods of Contraception, and Risk Reduction for Ovarian Cancer

M. Morgan, J. Grisso, R. Ness, 2001, Epidemiology.

Risk of Colorectal Cancer in Women With a Prior Diagnosis of Gynecologic Malignancy

M. Morgan, J. Lewis, S. Rubin, 2007, Journal of clinical gastroenterology.

Disparities in cancer-specific and overall survival in black women with endometrial cancer: A Medicare-SEER study

M. Morgan, C. Brensinger, A. Haggerty, 2022, Gynecologic oncology reports.

Decreasing the cesarean section rate in a private hospital: success without mandated clinical changes.

M. Morgan, D. Lagrew, 1996, American journal of obstetrics and gynecology.

Long-term complications of chemotherapy

M. Morgan, S. Rubin, 1998 .

Isolated distant lymph node metastases in ovarian cancer. Should a new substage be created?

R. Burger, M. Morgan, A. Haggerty, 2019, Gynecologic oncology reports.

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma.

M. Morgan, Lin Zhang, G. Coukos, 2005, Human gene therapy.

The ability to evaluate prognostic variables on frozen section in hysterectomies performed for endometrial carcinoma.

M. Morgan, V. Livolsi, E. Lusk, 1991, Gynecologic oncology.

Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group.

M. Morgan, J. Rader, R. Schilder, 2000, Gynecologic oncology.

Lack of efficacy of 24-h infusional topotecan in platinum-refractory ovarian cancer: A Gynecologic Oncology Group trial.

M. Morgan, T. Herzog, P. Rose, 1999, Gynecologic oncology.

Secondary Cytoreduction in Epithelial Ovarian Cancer

M. Morgan, J. Mikuta, 1998, Critical reviews in oncology/hematology.

Mutations of the BRCA2 gene in ovarian carcinomas.

F. Couch, M. Morgan, B. Weber, 1996, Cancer research.

Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.

M. Morgan, A. Sood, P. Fracasso, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Pyrazoloacridine in Recurrent Platinum-Resistant Ovarian Cancer: A Gynecologic Oncology Group Study

M. Morgan, J. Blessing, S. Plaxe, 2002, American journal of clinical oncology.

Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer.

M. Morgan, D. Porter, P. O'Neil, 1997, Gynecologic oncology.

Database management for a gynecologic oncology service.

M. Morgan, R. Giuntoli, J. Mikuta, 1990, Gynecologic oncology.

Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database.

M. Morgan, A. Haggerty, E. Ko, 2022, Gynecologic oncology.

Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer.

M. Morgan, A. Haggerty, E. Ko, 2020, Gynecologic oncology.

Naturally occurring insulin autoantibodies in neonates of normal pregnancies and their relationship to insulinemia and birth weight.

M. Morgan, S. Wellik, K. Berkowitz, 1995, American journal of obstetrics and gynecology.

Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group.

M. Morgan, J. Parer, A. Cnaan, 1999, American journal of obstetrics and gynecology.

CORTICAL BLINDNESS AND ANTON SYNDROME IN A PATIENT WITH OBSTETRIC HEMORRHAGE

M. Morgan, P. Argenta, 1998, Obstetrics and gynecology.

Survival of BRCA1 negative ovarian cancer patients based on family history.

M. Morgan, S. Rubin, C. Bandera, 2001, Gynecologic oncology.

Effect of patient education on palliative care knowledge and acceptability of outpatient palliative care services among gynecologic oncology patients: A randomized controlled trial.

R. Burger, M. Morgan, H. Bogner, 2019, Gynecologic oncology.

Severity of asthma and perinatal outcome.

M. Morgan, J. Perlow, C. Towers, 1992 .

Cervical cancer.

Kathleen R. Cho, M. Morgan, N. Dupont, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study

M. Morgan, P. Ramirez, J. Kavanagh, 2007, International Journal of Gynecologic Cancer.

Cisplatin plus gemcitabine in platinum-refractory ovarian or primary peritoneal cancer: a phase II study of the Gynecologic Oncology Group.

M. Morgan, P. Hanjani, J. Blessing, 2006, Gynecologic oncology.

Lymphadenectomy is associated with an increased risk of postoperative venous thromboembolism in early stage endometrial cancer.

M. Morgan, C. Brensinger, E. Ko, 2021, Gynecologic oncology.

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study.

M. Morgan, S. Waggoner, S. Rubin, 2011, Gynecologic oncology.

Intraperitoneal chemotherapy for ovarian cancer.

M. Morgan, 2008, Advances in experimental medicine and biology.

Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer.

M. Morgan, R. Coleman, M. Markman, 2005, Gynecologic oncology.

Effect of surgical debulking on survival in stage IV ovarian cancer.

M. Morgan, S. King, I. Benjamin, 1997, Gynecologic oncology.

Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer.

R. Burger, M. Morgan, A. Haggerty, 2020, Surgical oncology.

Phase II trial of CI-958 in recurrent platinum-refractory ovarian carcinoma. A Gynecologic Oncology Group Study.

M. Morgan, J. Blessing, M. Hoffman, 2000, Gynecologic oncology.

Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.

M. Morgan, W. Andersen, J. Blessing, 2003, Gynecologic oncology.

Sources of palliative care knowledge among patients with advanced or metastatic gynecologic cancer.

M. Morgan, A. Haggerty, Lainie P. Martin, 2020, Journal of pain and symptom management.

An increase in multi-site practices: The shifting paradigm for gynecologic cancer care delivery.

R. Burger, M. Morgan, A. Haggerty, 2020, Gynecologic oncology.

A prospective cross-sectional survey comparing patient and provider expectations regarding ovarian cancer prognosis

M. Morgan, A. Haggerty, S. Huepenbecker, 2022, Gynecologic oncology reports.

Advanced stage primary mucinous ovarian carcinoma. Where do we stand ?

R. Burger, M. Morgan, A. Haggerty, 2020, Archives of Gynecology and Obstetrics.

Role of adjuvant chemotherapy in the management of stage IC ovarian granulosa cell tumors

R. Burger, M. Morgan, A. Haggerty, 2019, Gynecologic oncology reports.

Patient and physician expectations and communication regarding ovarian cancer prognosis

M. Morgan, A. Haggerty, S. Huepenbecker, 2017 .

Performance of lymphadenectomy for apparent early stage malignant ovarian germ cell tumors in the era of platinum-based chemotherapy.

R. Burger, M. Morgan, A. Haggerty, 2020, Gynecologic oncology.

Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary.

M. Morgan, A. Haggerty, E. Ko, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma.

R. Burger, M. Morgan, A. Haggerty, 2019, Gynecologic oncology.

Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors

M. Morgan, A. Haggerty, E. Ko, 2021, International Journal of Gynecological Cancer.

Pathology Consultation for the Gynecologic Oncologist: What the Surgeon Wants to Know.

M. Morgan, L. Cory, 2018, Archives of pathology & laboratory medicine.

Extended-field radiation therapy in early-stage cervical carcinoma: survival and complications.

M. Morgan, B. Corn, S. King, 1991, Gynecologic oncology.

Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium

M. Morgan, A. Haggerty, E. Ko, 2020, International Journal of Gynecological Cancer.

A rapidly growing fetal teratoma

M. Morgan, T. Crombleholme, N. Adzick, 1997, The Lancet.

A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)

B. Monk, M. Morgan, D. Provencher, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of stage II endometrial carcinoma.

M. Morgan, J. Mikuta, J. Carlson, 1989, Gynecologic oncology.

Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study.

M. Morgan, S. Srinivas, J. Novi, 2005, The Journal of urology.

A retrospective analysis of Erb's palsy cases and their relation to birth weight and trauma at delivery.

M. Morgan, E. Graham, I. Forouzan, 1997, The Journal of maternal-fetal medicine.

Recurrence of gestational diabetes: who is at risk?

M. Morgan, J. Weeks, C. Major, 1998, American journal of obstetrics and gynecology.

Gestational diabetes: does the presence of risk factors influence perinatal outcome?

M. Morgan, J. Weeks, C. Major, 1994, American journal of obstetrics and gynecology.

Perinatal outcome in pregnancy complicated by massive obesity

M. Morgan, J. Perlow, C. Towers, 1993, American journal of obstetrics and gynecology.

Naturally occurring normal pregnancies and birth weight insulin autoantibodies in neonates of and their relationship to insulinemia

M. Morgan, S. Wellik, K. Berkowitz, 1995 .

Assessment of poor functional status and post-acute care needs following primary ovarian cancer debulking surgery

M. Morgan, C. Brensinger, E. Ko, 2020, International Journal of Gynecological Cancer.

ANTENATAL CORTICOSTEROID (ANCS) USE IN PRETERM LABOR IN THE USA. 647

M. Morgan, J. Parer, A. Cnaan, 1996, Pediatric Research.

Adjuvant chemotherapy for stage I high-intermediate risk endometrial carcinoma with lymph-vascular invasion

M. Morgan, A. Haggerty, E. Ko, 2022, International Journal of Gynecological Cancer.

Cervical cancer: Clinical practice guidelines in oncology

Kathleen R. Cho, M. Morgan, N. Dupont, 2013 .

Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database.

M. Morgan, A. Haggerty, E. Ko, 2021, Surgical oncology.

Antepartum surveillance for a history of stillbirth: when to begin?

M. Morgan, S. Thomas, J. Weeks, 1995, American journal of obstetrics and gynecology.

Antepartum surveillance When to begin? for a history of stillbirth:

M. Morgan, J. Weeks, M. Nageotte, 1995 .

Sexual function following hysterectomy for endometrial cancer: A five-year follow up investigation.

R. Burger, M. Morgan, L. Buckingham, 2017, Gynecologic oncology.

The impact of amniotic fluid volume assessed intrapartum on perinatal outcome.

M. Morgan, T. Garite, C. Baron, 1995, American journal of obstetrics and gynecology.

Sexual function in women after rectocele repair with acellular porcine dermis graft vs site-specific rectovaginal fascia repair

M. Morgan, C. Bradley, J. Novi, 2007, International Urogynecology Journal.

Labor and delivery management of the multiple gestation.

M. Morgan, C. Major, M. de Veciana, 1995, Obstetrics and gynecology clinics of North America.

Candida Chorioamnionitis After Serial Therapeutic Amniocenteses: A Possible Association

M. Morgan, E. Ruchelli, M. Rode, 2000, Journal of Perinatology.

Vaginal and bladder angiosarcoma after therapeutic irradiation.

M. Morgan, G. Thurnau, C. Pippitt, 1989, Southern medical journal.

Diagnosis of fetal renal anomalies.

M. Morgan, D. Stamilio, 1998, Obstetrics and gynecology clinics of North America.

Intrapartum masses: The procedure airway management for giant fetal neck EXIT (ex utero intrapartum treatment)

M. Morgan, A. Hubbard, C. D. Kurth, 1997 .

Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.

M. Morgan, A. Berchuck, B. Weber, 1996, The New England journal of medicine.

Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer.

D. Torigian, R. Burger, M. Morgan, 2021, Gynecologic oncology.

Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25,157 Women with Ovarian Cancer from 47 Epidemiological Studies

Andy H. Lee, A. Whittemore, V. Beral, 2012, PLoS medicine.

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer.

M. Morgan, A. Okamoto, D. Cella, 2019, The New England journal of medicine.

Integrated Analysis of Genetic Ancestry and Genomic Alterations across Cancers.

T. Rebbeck, M. Morgan, Lin Zhang, 2018, Cancer cell.

A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study

B. Monk, M. Morgan, C. Aghajanian, 2017 .

Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.

F. Bushman, M. Morgan, K. Bittinger, 2018, JCI insight.

Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of Müllerian origin.

M. Morgan, C. Drescher, D. Dizon, 2019, Gynecologic oncology.

Sexual function in women with pelvic organ prolapse compared to women without pelvic organ prolapse.

M. Morgan, J. Novi, L. Arya, 2005, The Journal of urology.

Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4‐cM region of chromosome 7q

M. Morgan, A. Berchuck, J. Boyd, 1998, Molecular carcinogenesis.

Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa

M. Morgan, M. Polan, A. Sleemi, 2009, International Urogynecology Journal.

Obstetric fistula.

M. Morgan, M. Polan, A. Sleemi, 2006, Nursing times.

Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.

M. Morgan, M. Birrer, V. Vathipadiekal, 2013, The Lancet. Oncology.

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.

M. Morgan, M. Egorin, R. Mannel, 2008, Gynecologic oncology.

Preterm premature rupture of membranes and abruptio placentae: is there an association between these pregnancy complications?

M. Morgan, D. Lewis, C. Major, 1995, American journal of obstetrics and gynecology.

The association between maternal cocaine use and placenta previa.

M. Morgan, J. Berlin, G. Macones, 1997, American journal of obstetrics and gynecology.

Antepartum cervical ripening: applying prostaglandin E2 gel in conjunction with scheduled nonstress tests in postdate pregnancies.

M. Morgan, K. Kennedy, D. Sassoon, 1998, American journal of obstetrics and gynecology.

Massive maternal obesity and perioperative cesarean morbidity.

M. Morgan, J. Perlow, 1994, American journal of obstetrics and gynecology.

Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis.

M. Morgan, A. Haggerty, E. Ko, 2020, Gynecologic oncology.

Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma.

M. Morgan, J. Boyd, V. Livolsi, 1997, Cancer research.

The "dangerous multipara": fact or fiction?

M. Morgan, J. Toohey, K. Keegan, 1995, American journal of obstetrics and gynecology.

Does station of the fetal head at epidural placement affect the position of the fetal vertex at delivery?

M. Morgan, G. Macones, C. A. Robinson, 1996, American journal of obstetrics and gynecology.

Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission

M. Morgan, P. Gimotty, G. Coukos, 2012, Cancer Immunology, Immunotherapy.

Phase II multicenter open‐label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study

M. Morgan, P. Ramirez, M. Pearl, 2008, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Cervical Cancer ScreeningPractice Guidelines in Oncology

Rochelle L. Garcia, M. Morgan, A. Giuliano, 2010 .

The fetal-pelvic index: a method of identifying fetal-pelvic disproportion in women attempting vaginal birth after previous cesarean delivery.

M. Morgan, G. Thurnau, D. Scates, 1991, American journal of obstetrics and gynecology.

Influence of labor and route of delivery on the frequency of respiratory morbidity in term neonates.

M. Morgan, G. Thurnau, K. Hales, 1994, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Abruptio placentae: perinatal outcome in normotensive and hypertensive patients.

M. Morgan, S. Thomas, K. Berkowitz, 1994, American journal of obstetrics and gynecology.

Effects of labetalol on uterine blood flow and cardiovascular hemodynamics in the hypertensive gravid baboon.

M. Morgan, K. Dormer, J. Fishburne, 1993, American journal of obstetrics and gynecology.

Effect of intravenous cocaine on uterine blood flow in the gravid baboon.

M. Morgan, R. E. Sheldon, R. Wentworth, 1991, American journal of obstetrics and gynecology.

Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma.

M. Morgan, S. Rubin, H. Gray, 2006, Gynecologic oncology.

Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial.

R. Burger, M. Morgan, S. Ellenberg, 2019, Obstetrics and gynecology.

A new questionnaire for urinary incontinence diagnosis in women: development and testing.

M. Morgan, J. Shea, C. Bradley, 2005, American journal of obstetrics and gynecology.

Acute urinary retention caused by a uterine leiomyoma: a case report.

A. Shaunik, M. Morgan, J. Novi, 2004, The Journal of reproductive medicine.

Acute urinary retention caused by a uterine leiomyoma.

A. Shaunik, M. Morgan, J. Novi, 2004 .

Predicting delivery within 48 hours in women treated with parenteral tocolysis.

M. Morgan, G. Macones, D. Stamilio, 1999, Obstetrics and gynecology.

Evidence for magnesium sulfate as a tocolytic agent.

M. Morgan, J. Berlin, G. Macones, 1997, Obstetrical & gynecological survey.

Interactions with industry under the Sunshine Act: an example from gynecologic oncology.

M. Morgan, M. Spillman, Monique A Spillman, 2016, American journal of obstetrics and gynecology.

Intravenous administration of cocaine stimulates gravid baboon myometrium in the last third of gestation

M. Morgan, P. Nathanielsz, S. Jenkins, 1994 .

Palliative fetal surgery for diaphragmatic hernia.

M. Morgan, J. Chang, R. Porreco, 1994, American journal of obstetrics and gynecology.

Selective delivery of an acardiac, acephalic twin.

M. Morgan, M. A. Morgan, G. Payne, 1989, The New England journal of medicine.

Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy.

M. Morgan, A. Evans, J. Toohey, 1995, The New England journal of medicine.

Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes.

M. Morgan, J. Holder, J. Strauss, 1999, American journal of obstetrics and gynecology.

Quantitative blood cultures in the diagnosis of sepsis in infants with umbilical and Broviac catheters.

M. Morgan, M. Morgan, A. Klein, 1988, The Journal of pediatrics.

The impact of sentinel lymph node sampling versus traditional lymphadenectomy on the survival of patients with stage IIIC endometrial cancer

M. Morgan, A. Haggerty, E. Ko, 2021, International Journal of Gynecological Cancer.

Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach

Mark Morgan, Sharon L. Manne, M. Morgan, 2017, Supportive Care in Cancer.

Uterine Neoplasms. Clinical Practice Guidelines in Oncology.

Kathleen R. Cho, M. Morgan, A. Secord, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Quality of oncologic care and outcomes of patients with endometrial cancer managed at minority-serving hospitals

M. Morgan, A. Haggerty, E. Ko, 2021, Gynecologic Oncology.

Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models

Mark Morgan, Eric Brown, Meenhard Herlyn, 2016, Clinical Cancer Research.

Outcomes of sentinel lymph node mapping for patients with FIGO stage I endometrioid endometrial carcinoma.

M. Morgan, A. Haggerty, E. Ko, 2021, Gynecologic oncology.

A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.

G. Mills, M. Morgan, R. Mach, 2017, JCI insight.

The fetal-pelvic index as an indicator of fetal-pelvic disproportion: a preliminary report.

M. Morgan, G. Thurnau, J. Fishburne, 1986, American journal of obstetrics and gynecology.

Does cesarean section decrease the incidence of major birth trauma?

M. Morgan, G. Macones, M. Mennuti, 1998, Journal of perinatology : official journal of the California Perinatal Association.

Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target

R. Burger, M. Morgan, R. Drapkin, 2020, JCI insight.

A Tumor Mitochondria Vaccine Protects against Experimental Renal Cell Carcinoma

M. Morgan, Jialing Huang, A. Facciabene, 2015, The Journal of Immunology.

2746 A Phase 2 open-label, multicenter study of single-agent rucaparib in the treatment of patients with relapsed ovarian cancer and a deleterious BRCA mutation

M. Morgan, A. Oza, Y. Drew, 2015 .

Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors

M. Morgan, K. Flaherty, P. O'dwyer, 2005, Cancer Chemotherapy and Pharmacology.

Pregnancy-induced hypertension without proteinuria: is it true preeclampsia?

M. Morgan, G. Thurnau, 1988, Southern medical journal.

Combined Anal Sphincteroplasty and Perineal Reconstruction for Fecal Incontinence in Women

M. Morgan, J. Novi, B. Mulvihill, 2009, The Journal of the American Osteopathic Association.

Efficacy of intraperitoneal sodium carboxymethylcellulose in preventing postoperative adhesion formation.

M. Morgan, G. Thurnau, C. Pippitt, 1994, The Journal of reproductive medicine.

Risk of Ovarian Cancer in Relation to Estrogen and Progestin Dose and Use Characteristics of Oral Contraceptives

M. Morgan, J. Grisso, J. Schlesselman, 2001 .

Low rate of intraperitoneal port placement in ovarian cancer patients, a population-based assessment

R. Burger, M. Morgan, C. Brensinger, 2019, International Journal of Gynecological Cancer.

Different patterns of myometrial activity and 24-h rhythms in myometrial contractility in the gravid baboon during the second half of pregnancy.

M. Morgan, R. Wentworth, P. Nathanielsz, 1992, Biology of reproduction.

Exercise Among Women With Ovarian Cancer: A Feasibility and Pre-/Post-Test Exploratory Pilot Study.

M. Morgan, K. Schmitz, E. Ko, 2017, Oncology nursing forum.

Evaluation of the fetal-pelvic relationship.

M. Morgan, G. Thurnau, M A Morgan, 1992, Clinical obstetrics and gynecology.

A Phase III Study of Pafolacianine Injection (OTL38) for Intraoperative Imaging of Folate Receptor–Positive Ovarian Cancer (Study 006)

M. Morgan, R. Wenham, A. Vahrmeijer, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The risk of periventricular-intraventricular hemorrhage with vacuum extraction of neonates weighing 2000 grams or less.

M. Morgan, S. Thomas, J. Weeks, 1997, Journal of perinatology : official journal of the California Perinatal Association.

Term Early‐Onset Neonatal Seizures: Obstetric Characteristics, Etiologic Classifications, and Perinatal Care

M. Morgan, J. Toohey, E. Quilligan, 1995, Obstetrics and gynecology.

Predictive factors for neonatal morbidity in neonates with an umbilical arterial cord pH less than 7.00.

M. Morgan, G. Macones, E. Graham, 1997, American journal of obstetrics and gynecology.

Perinatal outcome in pregnancy complicated by massive obesity.

M. Morgan, C. Towers, M. Porto, 1992 .

Cervical Cancer

Kathleen R. Cho, M. Morgan, A. Secord, 2015, Methods in Molecular Biology.

A comparison of two psychological interventions for newly-diagnosed gynecological cancer patients.

D. Kashy, M. Morgan, S. Manne, 2017, Gynecologic oncology.

Efficacy of the fetal-pelvic index in nulliparous women at high risk for fetal-pelvic disproportion.

M. Morgan, G. Thurnau, 1992, American journal of obstetrics and gynecology.

Logothetopulos pack for the management of uncontrollable postpartum hemorrhage.

M. Morgan, G. Payne, G. Robie, 1990, American journal of perinatology.

Efficacy of the fetal-pelvic index as a predictor of fetal-pelvic disproportion in women with abnormal labor patterns that require labor augmentations.

M. Morgan, G. Thurnau, 1988, American journal of obstetrics and gynecology.

Efficacy of the fetal-pelvic index in patients requiring labor induction

M. Morgan, G. Thurnau, 1988 .

Uterus didelphys with unilateral hematocolpos, ipsilateral renal agenesis and menses. A case report and literature review.

M. Morgan, G. Thurnau, M. Smith, 1987, The Journal of reproductive medicine.

Surgical management of vulvar cancer.

M. Morgan, J. Mikuta, 1999, Seminars in surgical oncology.

Bilateral simultaneous tubal pregnancy: case report and review of the literature.

M. Morgan, M. Edelstein, 1989, Obstetrical & gynecological survey.

Conservative management of vesicouterine fistula after uterine rupture

A. Shaunik, P. Ramchandani, M. Morgan, 2004, International Urogynecology Journal.

The clinical course of deep vein thrombosis in patients with gynecologic cancer.

M. Morgan, S. Rubin, J. Mikuta, 2002, Gynecologic oncology.

Therapy processes, progress, and outcomes for 2 therapies for gynecological cancer patients

D. Kashy, M. Morgan, S. Manne, 2017, Psycho-oncology.

Antenatal Thyrotropin Releasing Hormone (TRH) for the Prevention of Chronic Lung Disease (CLD) in the Preterm Infant. • 1461

M. Morgan, J. Pinto-Martin, J. Padbury, 1997, Pediatric Research.

Randomized trial comparing post-prandial vs. pre-prandal glucose monitoring in class A2 gestational diabetics

M. Morgan, C. Major, T. Asrat, 1995 .

A Formula for Predicting the Risk of a Positive Second-Look Laparotomy in Epithelial Ovarian Cancer: Implications for a Randomized Trial

M. Morgan, S. King, JOHN J. MIKUTA, 1992, Obstetrics and gynecology.

Women with a Prior Diagnosis of Breast Cancer Are Not at an Increased Risk for Subsequent Colorectal Cancer

M. Morgan, J. Lewis, S. Rubin, 2003, The American Journal of Gastroenterology.

Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma?

M. Morgan, A. Haggerty, E. Ko, 2021, Surgical oncology.

Pelvic organ prolapse, constipation, and dietary fiber intake in women: a case-control study.

A. Shaunik, M. Morgan, C. Bradley, 2005, American journal of obstetrics and gynecology.

Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecological cancers.

D. Kashy, M. Morgan, S. Manne, 2013, Gynecologic oncology.

Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program

R. Burger, M. Morgan, E. Ko, 2016, International Journal of Gynecologic Cancer.

Cocaine's effect on plasma oxytocin concentrations in the baboon during late pregnancy.

M. Morgan, P. Nathanielsz, C. Mecenas, 1996, American journal of obstetrics and gynecology.

Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology.

M. Morgan, C. Brensinger, A. Haggerty, 2020, Gynecologic oncology.

The specialty of gynecologic oncology as perceived by the public.

M. Morgan, S. King, R. Giuntoli, 1992, Gynecologic oncology.

Occult bilateral involvement in stage I epithelial ovarian cancer.

M. Morgan, I. Benjamin, S. Rubin, 1999, Gynecologic oncology.

OCCULT BILATERAL INVOLVEMENT IN STAGE I EPITHELIAL OVARIAN CANCER

M. Morgan, I. Benjamin, S. Rubin, 1999 .

Combination of PARP and ATR inhibitors (olaparib and ceralasertib) shows clinical activity in acquired PARP inhibitor-resistant recurrent ovarian cancer.

D. Torigian, M. Morgan, I. Shih, 2021 .

Intrapartum electronic fetal heart rate monitoring versus intermittent auscultation: a meta-analysis.

M. Morgan, T J Bader, M A Morgan, 1995, Obstetrics and gynecology.

Advanced maternal age: perinatal outcome when controlling for physician selection.

M. Morgan, D. Lagrew, K. Nakamoto, 1996, Journal of perinatology : official journal of the California Perinatal Association.

Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.

R. Burger, M. Morgan, C. Brensinger, 2017, Obstetrics and gynecology.

Post-Surgical Readmissions Among Women Undergoing Benign and Malignant Gynecologic Surgery [17]

M. Morgan, E. Ko, R. Giuntoli, 2016, Obstetrics and gynecology.

Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.

M. Morgan, A. Haggerty, E. Ko, 2019, Gynecologic oncology.

Impact of past surgical history on perioperative outcomes in gynecologic surgery.

M. Morgan, E. Ko, L. Cory, 2021, Gynecologic oncology.

Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.

M. Morgan, J. Java, P. Rose, 2016, Gynecologic oncology.

The ability to evaluate prognostic variables on frozen section in hysterectomies performed for endometrial carcinoma

M. Morgan, V. Livolsi, E. Lusk, 1992 .

Anti-mesothelin chimeric antigen receptor T cells in patients with epithelial ovarian cancer.

M. Morgan, D. Porter, C. June, 2016 .

The prescription or proscription of exercise in endometrial cancer care.

M. Morgan, K. Schmitz, Justin C. Brown, 2015, Gynecologic oncology.

Mutation analysis of the BRCA1 gene in ovarian cancers.

M. King, F. Couch, M. Morgan, 1995, Cancer research.

Another view of “humanitarian ventures” and “fistula tourism”

M. Morgan, 2007, International Urogynecology Journal.

Ovarian cancer and smoking: individual participant meta-analysis including 28 114 women with ovarian cancer from 51 epidemiological studies

Andy H. Lee, A. Whittemore, V. Beral, 2012, The Lancet. Oncology.

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

B. Monk, T. Kolevska, M. Morgan, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

B. Monk, T. Kolevska, M. Morgan, 2017 .

Intrapartum diagnosis of fetal macrosomia: Is ultrasound superiord to clinical estimation?

M. Morgan, J. Weeks, J. Spinnato, 1995 .

Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.

M. Morgan, G. Fleming, R. Mannel, 2018, Gynecologic Oncology.

Race-based disparities in loss of functional independence after hysterectomy for uterine cancer

R. Burger, M. Morgan, K. Schmitz, 2016, Supportive Care in Cancer.

Principles and practice of intraperitoneal chemotherapy for ovarian cancer

M. Morgan, D. Armstrong, M. Markman, 2006, International Journal of Gynecologic Cancer.

Postprandial Versus Preprandial Blood Glucose Monitoring in Women With Gestational Diabetes Mellitus Requiring Insulin Therapy

M. Morgan, J. Toohey, C. Major, 1996 .

Pembrolizumab in advanced endometrial cancer: Preliminary results from the phase Ib KEYNOTE-028 study.

M. Morgan, H. Rugo, Y. Bang, 2016 .

Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: a phase I and feasibility trial of the Gynecologic Oncology Group.

M. Morgan, M. Egorin, R. Mannel, 2008, Gynecologic oncology.

Abstract A72: Combination ATR and PARP inhibitor (CAPRI) for recurrent, platinum-resistant ovarian cancer

R. Burger, M. Morgan, S. Domchek, 2020 .